Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
25,018,920
-
Shares change
-
+2,583,446
-
Total reported value, excl. options
-
$1,750,601,005
-
Value change
-
+$226,035,991
-
Put/Call ratio
-
46%
-
Number of buys
-
113
-
Number of sells
-
65
-
Price
-
$69.98
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2020
As of 30 Jun 2020 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,018,920 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, KPS Global Asset Management UK Ltd, 683 Capital Management, LLC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and Antipodean Advisors LLC.
This table shows 164 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.